Extracellular histones, cell-free DNA, or nucleosomes: Differences in immunostimulation

Cell Death and Disease

Volumn 7, Issue 12, 2016, Pages

  Marsman, Gerben ^a   Zeerleder, Sacha ^a,b   Luken, Brenda M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BACTERIAL DNA; CASPASE 11; CELL FREE DNA; CELL NUCLEUS DNA; DNA; EXTRACHROMOSOMAL DNA; HISTONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MITOCHONDRIAL DNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; NUCLEOSOME;

ANIMAL CELL; BONE MARROW DERIVED DENDRITIC CELL; CAPILLARY ENDOTHELIAL CELL; CELL DEATH; CELL SURFACE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLYCOCALYX; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROPTOSIS; REVIEW; UPREGULATION; ANIMAL; DISEASES; EXTRACELLULAR SPACE; IMMUNIZATION; METABOLISM;

ANIMALS; DISEASE; DNA; EXTRACELLULAR SPACE; HISTONES; HUMANS; IMMUNIZATION; NUCLEOSOMES;

EID: 85021644122     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.410     Document Type: Review

References (99)

1. Allam R, Kumar SVR, Darisipudi MN, Anders HJ. Extracellular histones in tissue injury and inflammation. J Mol Med 2014; 92: 465–472.
2. Gould TJ, Lysov Z, Liaw PC. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost 2015; 13: S82–S91.
3. Magna M, Pisetsky DS. The alarmin properties of DNA and DNA-associated nuclear proteins. Clin Ther 2016; 38: 1029–1041.
4. Szerlong HJ, Herman JA, Krause CM, DeLuca JG, Skoultchi A, Winger QA et al. Proteomic characterization of the nucleolar linker histone H1 interaction network. J Mol Biol 2015; 427: 2056–2071.
5. Clausell J, Happel N, Hale TK, Doenecke D, Beato M. Histone H1 subtypes differentially modulate chromatin condensation without preventing ATP-dependent remodeling by SWI/ SNF or NURF. PLoS One 2009; 4: e0007243.
6. Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol 2012; 144: 32–40.
7. Chen R, Kang R, Fan X-G, Tang D. Release and activity of histone in diseases. Cell Death Dis 2014; 5: e1370.
8. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15: 1318–1321.
9. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011; 187: 2626–2631.
10. Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hägele H, Lichtnekert J et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012; 23: 1375–1388.
11. Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54: 999–1008.
12. Campbell JD, Cho Y, Foster ML, Kanzler H, Kachura MA, Lum JA et al. CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans. J Clin Invest 2009; 119: 2564–2576.
13. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013; 187: 160–169.
14. Gillrie MR, Lee K, Gowda DC, Davis SP, Monestier M, Cui L et al. Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction. Am J Pathol 2012; 180: 1028–1039.
15. Wildhagen KCAA, García de Frutos P, Reutelingsperger CP, Schrijver R, Aresté C, Ortega-Gómez A et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 2014; 123: 1098–1101.
16. Chaaban H, Keshari RS, Silasi-Mansat R, Popescu NI, Mehta-D’Souza P, Lim Y-P et al. Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury. Blood 2015; 125: 2286–2296.
17. Mishra B, von der Ohe M, Schulze C, Bian S, Makhina T, Loers G et al. Functional role of the interaction between polysialic acid and extracellular histone H1. J Neurosci 2010; 30: 12400–12413.
18. Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Boehringer M, Loesche W et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 2014; 18: 543.
19. Allam R, Darisipudi MN, Tschopp J, Anders H-J. Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Eur J Immunol 2013; 43: 3336–3342.
20. Huang H, Chen H-W, Evankovich J, Yan W, Rosborough BR, Nace GW et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J Immunol 2013; 191: 2665–2679.
21. Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev 2015; 265: 130–142.
22. Linkermann A, Stockwell BR, Krautwald S, Anders H-J. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol 2014; 14: 759–767.
23. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 321: 209–213.
24. Khan ME, Borde C, Rocha EPC, Mériaux V, Maréchal V, Escoll P et al. TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA. PLoS Negl Trop Dis 2014; 8: e3308.
25. Deng GM, Nilsson IM, Verdrengh M, Collins LV TA. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999; 5: 702–705.
26. Bhagirath VC, Dwivedi DJ, Liaw PC. Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA. Shock 2015; 44: 265–271.
27. Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631–1640.
28. Gowda NM, Wu X, Gowda DC. The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One 2011; 6: e20398.
29. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709–760.
30. Gaipl US, Beyer TD, Heyder P, Kuenkele S, Böttcher A, Voll RE et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 2004; 50: 640–649.
31. Ben Chetrit E, Dunsky EH, Wollner S, Eilat D. In vivo clearance and tissue uptake of an anti-DNA monoclonal antibody and its complexes with DNA. Clin Exp Immunol 1985; 60: 159–168.
32. Sirois CM, Jin T, Miller AL, Bertheloot D, Nakamura H, Horvath GL et al. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J Exp Med 2013; 210: 2447–2463.
33. Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007–3018.
34. Li Y, Berke IC, Modis Y. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J 2012; 31: 919–931.
35. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006; 7: 49–56.
36. Haas T, Metzger J, Schmitz F, Heit A, Müller T, Latz E et al. The DNA sugar backbone 2’ deoxyribose determines toll-like receptor 9 activation. Immunity 2008; 28: 315–323.
37. Cavlar T, Ablasser A, Hornung V. Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol Cell Biol 2012; 90: 474–482.
38. Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity 2016; 44: 739–754.
39. Rönnefarth VM, Erbacher AIM, Lamkemeyer T, Madlung J, Nordheim A, Rammensee H-G et al. TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. J Immunol 2006; 177: 7740–7749.
40. Lindau D, Rönnefarth V, Erbacher A, Rammensee H-G, Decker P. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Eur J Immunol 2011; 41: 669–681.
41. Decker P, Singh-Jasuja H, Haager S, Kötter I, Rammensee H-G. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 2005; 174: 3326–3334.
42. Hefeneider SH, Cornell KA, Brown LE, Bakke AC, McCoy SL, Bennett RM. Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol 1992; 63: 245–251.
43. Watson K, Gooderham NJ, Davies DS, Edwards RJ. Nucleosomes bind to cell surface proteoglycans. J Biol Chem 1999; 274: 21707–21713.
44. Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach JF. Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 1996; 26: 472–486.
45. Coritsidis GN, Beers PC, Rumore PM. Glomerular uptake of nucleosomes: evidence for receptor-mediated mesangial cell binding. Kidney Int 1995; 47: 1258–1265.
46. Gauthier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 1996; 156: 1151–1156.
47. Abrams ST, Zhang N, Dart C, Wang SS, Thachil J, Guan Y et al. Human CRP defends against the toxicity of circulating histones. J Immunol 2013; 191: 2495–2502.
48. Decker P, Wolburg H, Rammensee HG. Nucleosomes induce lymphocyte necrosis. Eur J Immunol 2003; 33: 1978–1987.
49. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim J-Y, Strassheim D et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290: C917–C924.
50. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191–195.
51. Tian J, Avalos AM, Mao S-Y, Chen B, Senthil K, Wu H et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487–496.
52. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172: 6692–6700.
53. Reich CF, Pisetsky DS. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res 2009; 315: 760–768.
54. Ullal AJ, Reich CF, Clowse M, Criscione-Schreiber LG, Tochacek M, Monestier M et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 2011; 36: 173–180.
55. Zeerleder S, Zwart B, te Velthuis H, Stephan F, Manoe R, Rensink I et al. Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP). FASEB J 2008; 22: 4077–4084.
56. Martin M, Leffler J, Smoląg KI, Mytych J, Björk A, Chaves LD et al. Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ 2016; 23: 903–911.
57. Stephan F, Marsman G, Bakker LM, Bulder I, Stavenuiter F, Aarden LA et al. Cooperation of factor VII-activating protease and serum DNase I in the release of nucleosomes from necrotic cells. Arthritis Rheumatol 2014; 66: 686–693.
58. Liang YY, Arnold T, Michlmayr A, Rainprecht D, Perticevic B, Spittler A et al. Serum-dependent processing of late apoptotic cells for enhanced efferocytosis. Cell Death Dis 2014; 5: e1264.
59. Rippe K, Mazurkiewicz J, Kepper N. Interactions of histones with DNA: nucleosome assembly, stability, dynamics, and higher order structure. In: Dias Rita, Björn Lindman O (ed). DNA Interactions with Polymers and Surfactants. John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2008, pp 135–172.
60. Martinez-Valle F, Balada E, Ordi-Ros J, Bujan-Rivas S, Sellas-Fernandez A, Vilardell-Tarres M. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features. Lupus 2009; 18: 418–423.
61. Marsman G, Stephan F, de Leeuw K, Bulder I, Ruinard JT, de Jong J et al. FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE. Eur J Immunol 2016; 46: 762–771.
62. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532–1535.
63. Goldmann O, Medina E. The expanding world of extracellular traps: Not only neutrophils but much more. Front Immunol 2012; 3: 1–10.
64. Saffarzadeh M, Juenemann C, Queisser M a, Lochnit G, Barreto G, Galuska SP et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012; 7: e32366.
65. Kumar SVR, Kulkarni OP, Mulay SR, Darisipudi MN, Romoli S, Thomasova D et al. Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN. J Am Soc Nephrol 2015; 26: 2399–2413.
66. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010; 191: 677–691.
67. Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008; 180: 1895–1902.
68. Schimmel M, Nur E, Biemond BJ, van Mierlo GJ, Solati S, Brandjes DP et al. Nucleosomes and neutrophil activation in sickle cell disease painful crisis. Haematologica 2013; 98: 1797–1803.
69. Van Montfoort ML, Stephan F, Lauw MN, Hutten B a, Van Mierlo GJ, Solati S et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol 2013; 33: 147–151.
70. Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2016; 119: 6335–6344.
71. Kim J-E, Lee N, Gu J-Y, Yoo HJ, Kim HK. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation. Thromb Res 2015; 135: 1064–1069.
72. de Jong HK, Koh GC, Achouiti A, van der Meer AJ, Bulder I, Stephan F et al. Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis). Intensive Care Med Exp 2014; 2: 21.
73. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661–2671.
74. Berkes E, Oehmke F, Tinneberg HR, Preissner KT, Saffarzadeh M. Association of neutrophil extracellular traps with endometriosis-related chronic inflammation. Eur J Obstet Gynecol Reprod Biol 2014; 183: 193–200.
75. Martinod K, Fuchs TA, Zitomersky NL, Wong SL, Demers M, Gallant M et al. PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood 2015; 125: 1948–1956.
76. Sun K, Jiang P, Chan KCA, Wong J, Cheng YKY, Liang RHS et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci USA 2015; 112: E5503–E5512.
77. Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld ABJ, Caliezi C et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947–1951.
78. Kutcher ME, Xu J, Vilardi RF, Ho C, Esmon CT, Cohen MJ. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg 2012; 73: 1389–1394.
79. Johansson P, Windeløv N, Rasmussen L, Sørensen A, Ostrowski S. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock 2013; 6: 171.
80. Geiger S, Holdenrieder S, Stieber P, Hamann GF, Bruening R, Ma J et al. Nucleosomes in serum of patients with early cerebral stroke. Cerebrovasc Dis 2006; 21: 32–37.
81. Barrero C A, Perez-Leal O, Aksoy M, Moncada C, Ji R, Lopez Y et al. Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 673–683.
82. Amoura Z, Piette JC, Chabre H, Cacoub P, Papo T, Wechsler B et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum 1997; 40: 2217–2225.
83. Nakahara M, Ito T, Kawahara K, Yamamoto M, Nagasato T, Shrestha B et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One 2013; 8: e75961.
84. Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012; 120: 1157–1164.
85. van Bijnen STA, Wouters D, van Mierlo GJ, Muus P, Zeerleder S. Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab. J Thromb Haemost 2015; 13: 2004–2011.
86. Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Fertig G, Fürst H et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer 2001; 95: 114–120.
87. Trejo-Becerril C, Pérez-Cárdenas E, Treviño-Cuevas H, Taja-Chayeb L, García-López P, Segura-Pacheco B et al. Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients. Int J Cancer 2003; 104: 663–668.
88. Van Montfoort ML, Stephan F, Lauw MN, Hutten BA, Van Mierlo GJ, Solati S et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol 2013; 33: 147–151.
89. Zeerleder S, Stephan F, Emonts M, de Kleijn ED, Esmon CT, Varadi K et al. Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Crit Care Med 2012; 40: 3224–3229.
90. Bosmann M, Grailer JJ, Ruemmler R, Russkamp NF, Zetoune FS, Sarma JV et al. Extracellular histones are essential effectors of C5aR-and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 2013; 27: 5010–5021.
91. Kawano H, Ito T, Yamada S, Hashiguchi T, Maruyama I, Hisatomi T et al. Toxic effects of extracellular histones and their neutralization by vitreous in retinal detachment. Lab Invest 2014; 94: 569–585.
92. Zeerleder S, Zwart B, te Velthuis H, Manoe R, Bulder I, Rensink I et al. A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS Lett 2007; 581: 5382–5388.
93. De Meyer SF, Suidan GL, Fuchs TA, Monestier M, Wagner DD. Extracellular chromatin is an important mediator of ischemic stroke in mice. Arterioscler Thromb Vasc Biol 2012; 32: 1884–1891.
94. Holdenrieder S, Eichhorn P, Beuers U, Samtleben W, Schoenermarck U, Zachoval R et al. Nucleosomal DNA fragments in autoimmune diseases. Ann NY Acad Sci 2006; 1075: 318–327.
95. Raffray L, Douchet I, Augusto J-F, Youssef J, Contin-Bordes C, Richez C et al. Septic shock sera containing circulating histones induce dendritic cell-regulated necrosis in fatal septic shock patients. Crit Care Med 2015; 43: e107–e116.
96. Wen Z, Liu Y, Li F, Ren F, Chen D, Li X et al. Circulating histones exacerbate inflammation in mice with acute liver failure. J Cell Biochem 2013; 114: 2384–2391.
97. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 69–74.
98. Chan KCA, Zhang J, Chan ATC, Lei KIK, Leung S, Chan LYS et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003; 63: 2028–2032.
99. Holdenrieder S. Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin Chem 2005; 51: 1544–1546.